Medindia LOGIN REGISTER
Medindia

Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets

by Kathy Jones on Jun 11 2011 5:54 PM

 Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
Hyderabad based pharmaceutical company, Aurobindo Pharma has revealed that it has got the approval from the US Food and Drug Administration to manufacture and market its hypertension drug, ramipril in the country.
Apart from high blood pressure, ramipril is also used in treating congestive heart failure (CHF) and the company said that it has gained approval to manufacture the drug in 1.25mg, 2.5mg, 5mg and 10mg strengths.

Recent figures released by the IMS have shown that the cardiovascular therapeutic segment in the United States generated sales of over $95 million in the year ending September 2010.

Source-Medindia


Advertisement